Literature DB >> 24949996

Neuropsychological Assessment Battery-Screening Module (S-NAB): performance in treatment-seeking cocaine users.

Daniela L Cannizzaro1, Jennifer C Elliott, Malka Stohl, Deborah S Hasin, Efrat Aharonovich.   

Abstract

UNLABELLED: Abstract Background: Cocaine use is associated with cognitive impairments, which can have a negative effect on treatment retention and drug use. Thus, there is an increasing demand for a screening cognitive battery can be used by clinicians to detect such impairments in cocaine patients so that treatment can be adapted to patients' specific cognitive strengths and deficits. The Neuropsychological Assessment Battery-Screening Module (S-NAB) test for adults takes approximately 35-45 min to administer, and assesses attention, language, memory (verbal and visual), visual spatial reasoning, and executive functioning.
OBJECTIVE: The purpose of this descriptive study was to present S-NAB score results for a sample of treatment seeking adult cocaine users to determine its potential utility for detecting cognitive impairments in this population.
METHODS: In the present sample, 145 adult cocaine users participated in screening to enroll in an intervention to decrease cocaine use (59% male; 73.1% African American); screening included the S-NAB and self-report questionnaires.
RESULTS: A substantial proportion of the sample (44%) met criteria for impairment, i.e. composite scores of one or more standard deviations below the mean. Furthermore, memory scores were significantly lower than language and spatial scores (p < 0.007).
CONCLUSIONS: The impairments detected by the S-NAB were generally consistent with those previously observed in samples of cocaine users completing other batteries, as well in other substance abusing samples completing the S-NAB. This suggests that the S-NAB can be considered an additional appropriate battery, as an alternative to other existing batteries, for assessment of the cognitive functioning of adult cocaine users.

Entities:  

Keywords:  Cocaine; cognitive performance; neuropsychology

Mesh:

Year:  2014        PMID: 24949996      PMCID: PMC4309379          DOI: 10.3109/00952990.2014.916718

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  39 in total

1.  Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals.

Authors:  Chris C Streeter; Devin B Terhune; Theodore H Whitfield; Staci Gruber; Ofra Sarid-Segal; Marisa M Silveri; Golfo Tzilos; Maryam Afshar; Elizabeth D Rouse; Hua Tian; Perry F Renshaw; Domenic A Ciraulo; Deborah A Yurgelun-Todd
Journal:  Neuropsychopharmacology       Date:  2007-06-13       Impact factor: 7.853

2.  Neuropsychological deficits in chronic cocaine abusers.

Authors:  A Ardila; M Rosselli; S Strumwasser
Journal:  Int J Neurosci       Date:  1991-03       Impact factor: 2.292

3.  Cognitive deficits predict low treatment retention in cocaine dependent patients.

Authors:  Efrat Aharonovich; Deborah S Hasin; Adam C Brooks; Xinhua Liu; Adam Bisaga; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2005-09-19       Impact factor: 4.492

4.  Ecological validity of the screening module and the Daily Living tests of the Neuropsychological Assessment Battery using the Mayo-Portland Adaptability Inventory-4 in postacute brain injury rehabilitation.

Authors:  Dennis J Zgaljardic; Sybil Yancy; Richard O Temple; Monica F Watford; Rebekah Miller
Journal:  Rehabil Psychol       Date:  2011-09-19

5.  Neuropsychological deficits associated with cannabis use in young adults.

Authors:  Jon E Grant; Samuel R Chamberlain; Liana Schreiber; Brian L Odlaug
Journal:  Drug Alcohol Depend       Date:  2011-09-14       Impact factor: 4.492

6.  Reliability and validity of the Neuropsychological Assessment Battery-Screening Module (NAB-SM) in a sample of patients with moderate-to-severe acquired brain injury.

Authors:  Dennis J Zgaljardic; Richard O Temple
Journal:  Appl Neuropsychol       Date:  2010-01

7.  Neurocognitive deficits in cocaine users: a quantitative review of the evidence.

Authors:  Diana Jovanovski; Suzanne Erb; Konstantine K Zakzanis
Journal:  J Clin Exp Neuropsychol       Date:  2005-02       Impact factor: 2.475

8.  [Neuropsychological impairments in crack cocaine-dependent inpatients: preliminary findings].

Authors:  Paulo J Cunha; Sergio Nicastri; Luciana P Gomes; Renata M Moino; Marco A Peluso
Journal:  Braz J Psychiatry       Date:  2004-10-27       Impact factor: 2.697

9.  Substance abuse treatment outcomes for cognitively impaired and intact outpatients.

Authors:  Gordon Teichner; Michael D Horner; John C Roitzsch; Janice Herron; Angelica Thevos
Journal:  Addict Behav       Date:  2002 Sep-Oct       Impact factor: 3.913

10.  A Web-Based Behavior Therapy Program Influences the Association Between Cognitive Functioning and Retention and Abstinence in Clients Receiving Methadone Maintenance Treatment.

Authors:  Michelle C Acosta; Lisa A Marsch; Haiyi Xie; Honoria Guarino; Yesenia Aponte-Melendez
Journal:  J Dual Diagn       Date:  2012-10
View more
  2 in total

Review 1.  A Roadmap for Integrating Neuroscience Into Addiction Treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine.

Authors:  Antonio Verdejo-Garcia; Valentina Lorenzetti; Victoria Manning; Hugh Piercy; Raimondo Bruno; Rob Hester; David Pennington; Serenella Tolomeo; Shalini Arunogiri; Marsha E Bates; Henrietta Bowden-Jones; Salvatore Campanella; Stacey B Daughters; Christos Kouimtsidis; Dan I Lubman; Dieter J Meyerhoff; Annaketurah Ralph; Tara Rezapour; Hosna Tavakoli; Mehran Zare-Bidoky; Anna Zilverstand; Douglas Steele; Scott J Moeller; Martin Paulus; Alex Baldacchino; Hamed Ekhtiari
Journal:  Front Psychiatry       Date:  2019-12-23       Impact factor: 4.157

Review 2.  Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods.

Authors:  Krista M Lisdahl; Kenneth J Sher; Kevin P Conway; Raul Gonzalez; Sarah W Feldstein Ewing; Sara Jo Nixon; Susan Tapert; Hauke Bartsch; Rita Z Goldstein; Mary Heitzeg
Journal:  Dev Cogn Neurosci       Date:  2018-02-21       Impact factor: 5.811

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.